255 related articles for article (PubMed ID: 4598802)
21. [Various immunological aspects of demyelinations. II. Attempts at the determination of immunological reactions in multiple sclerosis].
Vymazal J; Krásenská-Dlabacová J
Cesk Neurol Neurochir; 1974 Jul; 37(4):240-6. PubMed ID: 4846373
[No Abstract] [Full Text] [Related]
22. Oligodendrocytes: the putative target cells of multiple sclerosis.
Abramsky O
Isr J Med Sci; 1982 Jan; 18(1):149-58. PubMed ID: 7040297
[No Abstract] [Full Text] [Related]
23. [Cyclophosphamide in the therapy of multiple sclerosis].
Salvatores U; Majeron M; Mascetti A
Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb; 96(1):163-84. PubMed ID: 4337775
[No Abstract] [Full Text] [Related]
24. [Immunological treatments in multiple sclerosis].
Abramsky O
Harefuah; 1981 Aug; 101(3-4):73-4. PubMed ID: 7319393
[No Abstract] [Full Text] [Related]
25. [Immunosuppressive treatment in multiple sclerosis].
Vermeulen M; Zegerius L; van Crevel H
Ned Tijdschr Geneeskd; 1987 Jan; 131(3):93-6. PubMed ID: 3821989
[No Abstract] [Full Text] [Related]
26. [Long-term therapeutic trials and multiple sclerosis: a wager?].
Confavreux C
Rev Neurol (Paris); 1983; 139(6-7):431-7. PubMed ID: 6412341
[No Abstract] [Full Text] [Related]
27. [Immunosuppressive treatment im multiple sclerosis].
Mertin J
Fortschr Med; 1980 Oct; 98(37):1431-6. PubMed ID: 6253370
[TBL] [Abstract][Full Text] [Related]
28. [Use of antilymphocyte globulin in autoimmune nervous system diseases].
Frick G; Preussner S; Perlberg KW
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):53-64. PubMed ID: 88390
[TBL] [Abstract][Full Text] [Related]
29. [Therapy of chronic lymphocytic leukemia].
Marmont A
Haematol Lat; 1969; 12(3):711-42. PubMed ID: 4097256
[No Abstract] [Full Text] [Related]
30. [Modern therapeutic viewpoints in the treatment of multiple sclerosis].
Neumayer E
Wien Med Wochenschr; 1969 Apr; 119(15):281-4. PubMed ID: 5769603
[No Abstract] [Full Text] [Related]
31. Current methods of therapy in multiple sclerosis.
Sibley WA
Mod Treat; 1970 Sep; 7(5):918-29. PubMed ID: 4326377
[No Abstract] [Full Text] [Related]
32. [Virus neutralizing and antibrain antibodies in multiple sclerosis and multiple encephalomyelitis].
Zinchenko AP; Shamreĭ RK
Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(4):541-8. PubMed ID: 4301248
[No Abstract] [Full Text] [Related]
33. [Pathogenesis and therapy of autoimmune diseases].
Burgio GR
Monatsschr Kinderheilkd (1902); 1972 Mar; 120(3):112-9. PubMed ID: 4401605
[No Abstract] [Full Text] [Related]
34. [Herpes simplex virus and multiple sclerosis: virological and serological studies].
Terni M; Luzzatto A
Riv Patol Nerv Ment; 1969 Apr; 90(2):113-20. PubMed ID: 4329795
[No Abstract] [Full Text] [Related]
35. [New knowledge on the treatment of multiple sclerosis patients].
Neu I
Fortschr Med; 1982 Dec; 100(45):2110. PubMed ID: 7173796
[No Abstract] [Full Text] [Related]
36. [Multiple sclerosis--an enigmatic disease].
Schrader A
Offentl Gesundheitswes; 1981 Aug; 43(8):360-4. PubMed ID: 6285239
[No Abstract] [Full Text] [Related]
37. [Multiple sclerosis--current status of therapy].
Reichel D; Kölmel HW
Z Arztl Fortbild (Jena); 1995 May; 89(2):151-8. PubMed ID: 7610682
[TBL] [Abstract][Full Text] [Related]
38. Treatment and prevention of myelin disorders: multiple sclerosis.
Abramsky O
Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():489-92. PubMed ID: 6326915
[No Abstract] [Full Text] [Related]
39. Immunosuppression and chemotherapeutic agents.
Kim Z
Ann Allergy; 1981 Aug; 47(2):79-83. PubMed ID: 7258742
[TBL] [Abstract][Full Text] [Related]
40. [Etiopathogenesis of multiple sclerosis in the light of current studies].
Strelau K
Neurol Neurochir Pol; 1972; 6(1):93-8. PubMed ID: 4553032
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
